British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritis

Susan P Mollan; Sarah L Mackie

doi:10.1136/practneurol-2020-002615

Article menu

Article
Text
Article
info
Citation
Tools
Share
Responses
Article
metrics
Alerts

PDF

A guide to guidelines

British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritis

Share this article

Click the icon of the social media platform on which you would like to share this article.

Share This Article:

Email this article to a friend

We will not keep your email address; we ask for it so your friend knows the email isn't spam.

Your email: *

Your name: *

Send to: *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following British Society for Rheumatology guideline for diagnosis and treatment of giant cell arteritis

Message subject: (Your Name) has forwarded a page to you from Practical Neurology

Message body: (Your Name) thought you would like to see this page from the Practical Neurology web site.

Your personal message:

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Read the full text or download the PDF:

Log in using your username and password

For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?

Forgot your user name or password?

Other content recommended for you

Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
Sarah Louise Mackie et al., Postgraduate Medical Journal, 2013
Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis
Carl Richard Svasti-Salee et al., BMJ Case Reports, 2019
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis
Sara Monti et al., RMD Open, 2019
Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET - CT) as a diagnostic and monitoring tool
Alwin Sebastian et al., RMD Open, 2020
Long - term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
Jobie Evans et al., RMD Open, 2016
Probability - based algorithm using ultrasound and additional tests for suspected GCA in a fast - track clinic
Alwin Sebastian et al., RMD Open, 2020
Stroke associated with giant cell arteritis: a population - based study
Maxime Samson et al., Journal of Neurology, Neurosurgery & Psychiatry, 2014
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich et al., Annals of the Rheumatic Diseases, 2019
Serum osteopontin: a biomarker of disease activity and predictor of relapsing course in patients with giant cell arteritis. Potential clinical usefulness in tocilizumab - treated patients
Sergio Prieto-González et al., RMD Open, 2017
Giant cell arteritis manifested by chronic dry cough
Hiroshi Hori et al., BMJ Case Reports, 2020

Log in using your username and password

Main menu

Log in using your username and password

You are here

Share this article

Email this article to a friend

Request permissions

Read the full text or download the PDF:

Log in using your username and password

Other content recommended for you